Participate in a clinical study of a potential treatment for Nonalcoholic steatohepatitis (NASH)
Purpose: to evaluate the safety and tolerability of an investigational medication that would work by increasing the percentage of sugars and fats that is consumed instead of stored in the liver.
There is one screening appointment, prior to two, 2 nights stays and PCR COVID testing
There is 7 outpatient visits
This study also includes 1 eye exams.
Reimbursement for study participation will be provided for time and travel of up to $5,380
We have worked with this investigational medication in previous clinical trials at Nucleus Network.
This study has been reviewed and approved by an independent ethics committee
Call 612-315-6490 to discuss your eligibility today!